Evaluation of Clinical Utility of Non-invasive Hemodynamic Monitoring Device

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Aug 10, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new non-invasive device called HemoVista, which monitors the blood flow and heart function of patients undergoing surgery with general anesthesia. The goal is to see how well this device works compared to a traditional method called FloTrac, which requires inserting a catheter into the body. Both devices aim to provide important information about a patient’s hemodynamic status, or how well their heart and blood vessels are working, during surgery.

To be eligible for this trial, participants need to be adults aged 20 or older who are having surgery that lasts more than two hours and require close monitoring with the FloTrac device. However, if a patient has any issues at the site where the HemoVista device would be attached, they cannot participate. Those who join the study can expect to be monitored with both devices during their surgery to help researchers understand which method provides better information without the need for invasive procedures. This trial is currently recruiting participants and welcomes individuals of any gender.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients aged 20 or older who undergo surgery under general anesthesia for more than two hours
• • invasive close hemodynamic monitoring with FloTrac is needed
• Exclusion Criteria:
• • problems in site where HemoVista is attached